KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 163 filers reported holding KARUNA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.33 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,412,236 | +100.8% | 20,180 | +157.5% | 0.00% | +100.0% |
Q2 2023 | $1,699,670 | +17.8% | 7,838 | -1.3% | 0.00% | 0.0% |
Q1 2023 | $1,442,948 | +21.1% | 7,944 | +31.0% | 0.00% | 0.0% |
Q4 2022 | $1,191,969 | +16.7% | 6,066 | +33.7% | 0.00% | 0.0% |
Q3 2022 | $1,021,000 | +232.6% | 4,538 | +86.9% | 0.00% | – |
Q2 2022 | $307,000 | +38.9% | 2,428 | +32.1% | 0.00% | – |
Q1 2021 | $221,000 | – | 1,838 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Pivotal bioVenture Partners Investment Advisor LLC | 797,008 | $134,766,083 | 53.75% |
Nan Fung Group Holdings Ltd | 225,688 | $38,161,584 | 30.90% |
Sofinnova Investments, Inc. | 1,381,149 | $233,538,484 | 14.73% |
First Light Asset Management, LLC | 303,137 | $51,257,435 | 4.87% |
Altium Capital Management LP | 34,000 | $5,749,060 | 3.00% |
DAFNA Capital Management LLC | 52,873 | $8,940,296 | 2.78% |
Logos Global Management LP | 115,000 | $19,445,350 | 2.59% |
GENERAL ATLANTIC, L.P. | 986,710 | $166,842,794 | 2.58% |
MPM BioImpact LLC | 53,210 | $8,997,279 | 2.40% |
Rock Springs Capital Management LP | 505,433 | $85,463,666 | 2.29% |